Pohlmann v. Purdue Pharma LP et al
James Pholmann and James Pohlmann |
Janssen Pharmaceutica Inc., Endo Health Solutions, Inc., Purdue Pharma LP, McKesson Corporation, MALLINCKRODT PLC, Insys Therapeutics, Inc., Allergan PLC, Watson Pharmaceuticals, Inc. n/k/a Actavis, Inc., Teva Pharmaceuticals USA, Inc., Actavis LLC, Cardinal Health, Inc., Actavis Pharma, Inc., Purdue Frederick Company, Inc., Watson Laboratories, Inc., MALLINCKRODT LLC, Purdue Pharma Inc, Johnson & Johnson, AmerisourceBergen Drug Corporation, Janssen Pharmaceuticals, Inc., Teva Pharmaceuticals Industries Ltd, Noramco, Inc., Cephalon, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc., MORRIS AND DICKSON CO., INC., Mallinckrodt, LLC, Morris & Dickson Co., Inc., Endo Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc. and Mallinckrodt, PLC |
2:2018cv09557 |
October 15, 2018 |
U.S. District Court for the Eastern District of Louisiana |
Michael North |
Sarah S Vance |
Racketeer/Corrupt Organization |
28 U.S.C. § 1332 |
Plaintiff |
Docket Report
This docket was last retrieved on December 3, 2018. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 22 Receipt of Transfer Case to Northern District of Ohio. (jeg) |
![]() |
Filing 20 Notice of Conditional Transfer Order from MDL Panel regarding MDL 2804. (jeg) |
![]() |
Filing 18 EXPARTE/CONSENT MOTION to Continue Hearing on Plaintiff's Motion for Remand by Janssen Pharmaceuticals, Inc., Johnson & Johnson, McKesson Corporation. (Attachments: #1 Proposed Order)(Williams, Stacey) |
![]() |
Filing 16 Request/Statement of Oral Argument by James Pohlmann regarding #15 MOTION to Remand to State Court (Attachments: #1 Proposed Order)(Leger, Walter) |
Filing 15 MOTION to Remand to State Court by James Pohlmann. Motion(s) will be submitted on 11/21/2018. (Attachments: #1 Memorandum in Support, #2 Notice of Submission, #3 Proposed Order)(Leger, Walter) |
Filing 14 Statement of Corporate Disclosure by Janssen Pharmaceuticals, Inc., Johnson & Johnson. Janssen Pharmaceuticals, Inc. identifying Corporate Parent Janssen Pharmaceutica Inc., Corporate Parent Ortho-McNeil-Janssen Pharmaceuticals, Inc., Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. (Rookard, Kelly) Modified text on 10/31/2018 (am). |
Filing 13 Notice of Compliance #1 Notice of Removal with 28 U.S.C. 1447(b) by Janssen Pharmaceuticals, Inc., Johnson & Johnson re #4 Order. (Attachments: #1 State Court Pleadings)(Rookard, Kelly) |
![]() |
Filing 11 Correction of Docket Entry by Clerk re #10 MOTION for Extension of Deadlines , #8 Statement of Corporate Disclosure, #9 Notice of Related Case(s), #7 Notice. **Name of attorney who electronically filed this document does not match name of signatory attorney on pleading. The user log-in and password serve as the required signature for purposes of Rule 11 of the FRCP. No further action is necessary.** (am) |
Filing 10 EXPARTE/CONSENT MOTION for Extension of Deadlines by AmerisourceBergen Drug Corporation, Cardinal Health, Inc., McKesson Corporation. (Attachments: #1 Proposed Order)(Williams, Stacey) |
Filing 9 Notice of Related Case(s) by McKesson Corporation. (Williams, Stacey) |
Filing 8 Statement of Corporate Disclosure by McKesson Corporation (Williams, Stacey) |
Filing 7 NOTICE by McKesson Corporation Supplemental Notice of Removal. (Attachments: #1 Exhibit)(Williams, Stacey) |
![]() |
Filing 5 EXPARTE/CONSENT MOTION for Extension of Time to Answer or Otherwise File Responsive Pleadings as to all Manufacturing Defendants by Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Attachments: #1 Proposed Order)(Rookard, Kelly) |
Filing 4 Directive of the Clerk regarding compliance with 28:1447(b) re #1 Notice of Removal, filed by Janssen Pharmaceuticals, Inc, Johnson & Johnson. By the Clerk.(am) |
Filing 3 Correction of Docket Entry by Clerk re #1 Notice of Removal,**Exhibit 2 was imaged as 8-1/2" x 14". All documents should be 8-1/2" x 11". Clerk has corrected the image.** (am) |
Filing 2 Initial Case Assignment to Judge Sarah S. Vance and Magistrate Judge Michael North. (cc) |
Filing 1 NOTICE OF REMOVAL from 34th Judicial District Court, St. Bernard Parish, case number 18-1218 A (Filing fee $ 400 receipt number 053L-7172178) filed by Janssen Pharmaceuticals, Inc., Johnson & Johnson. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Collateral Pleadings Notice)Attorney Kelly Juneau Rookard added to party Janssen Pharmaceuticals, Inc.(pty:dft), Attorney Kelly Juneau Rookard added to party Johnson & Johnson(pty:dft).(Rookard, Kelly) Modified text on 10/16/2018 (am). (Attachment 3 replaced on 10/16/2018) (am). |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Louisiana Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.